Currently, all therapy for glaucoma is directed at lowering eye pressure, but the fundamental problem in glaucoma is the degeneration of the optic nerve fibers necessary for vision.
Read More »“A Clear Path to Vision Restoration” — On October 16, 2018 Jeffrey Goldberg, MD, PhD delivered the Weston Glaucoma Research Lecture in Palo Alto, Calif., presented by Glaucoma Research Foundation.
Read More »For her research project exploring the role of oxygen and antioxidant levels in the eye, Dr. Carla Siegfried was awarded the 2018 Shaffer Prize for Innovative Glaucoma Research.
Read More »
The Catalyst for a Cure Biomarker team of scientists has received important peer acknowledgment in key science publications.
Read More »Each year I attend ARVO to learn about the latest glaucoma research and connect with our friends and supporters. Each year I come away excited about the potential to make a real difference in glaucoma research.
Read More »Glaucoma Research Foundation awards annual research grants for creative pilot projects that hold promise.
Read More »In this video, Dr. Brandt discusses the main takeaway messages from the 2018 New Horizons Forum session on Glaucoma Drug Delivery and his outlook on the future of drug delivery platforms for treating glaucoma.
Read More »
The Catalyst for a Cure (CFC) Biomarker scientists are now evaluating their novel biomarkers in glaucoma patients. Read about their progress in this report.
Read More »In this interview for Glaucoma Research Foundation, Dr. Janey Wiggs discusses the main take home messages from her lecture at AAO 2017 and why genetics are significant in glaucoma research.
Read More »Janey L. Wiggs, MD, PhD (Harvard Medical School/Massachusetts Eye and Ear) discusses genetics in glaucoma research and why she is optimistic about the future of glaucoma management.
Read More »
